Bye-bye urinary gonadotrophins?

Authors: Roberto Matorras; Francisco J. Rodríguez-Escudero

Source: Human Reproduction, Volume 17, Number 7, July 2002 , pp. 1675-1675(1)

Buy & download fulltext article:

Price: $44.11 plus tax (Refund Policy)

Abstract:

In view of concerns regarding the potential presence and infectivity of prion proteins in human urinary gonadotrophin preparations, together with the availability of both recombinant FSH and recombinant LH, it is argued that the use of urinary gonadotrophins should be discouraged.

Keywords: BSE; new variant CJD; TSE; urinary gonadotrophins

Document Type: Research article

Affiliations: 1: Human Reproduction Unit, Hospital de Cruces, País Vasco University, Baracaldo, Vizcaya, Spain

Publication date: 2002-07-01

More about this publication?

Human Reproduction features full-length, peer-reviewed papers reporting original research, clinical case histories, as well as opinions and debates on topical issues. Papers published cover the scientific and medical aspects of reproductive physiology and pathology, endocrinology, andrology, gonad function, gametogenesis, fertilization, embryo development, implantation, pregnancy, genetics, genetic diagnosis, oncology, infectious disease, surgery, contraception, infertility treatment, psychology, ethics and social issues. The highest scientific and editorial standard is maintained throughout the journal along with a rapid rate of publication.